FIELD: pharmacology. SUBSTANCE: preservation of therapeutic agents is accomplished by using, as preservative, colloidal solution of silicic acid at pH 7.5-8.5 and concentration of silicic acid 4-6%. EFFECT: suppressed development of bacteria owing to formation of rigid gel. 2 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING GEL-LIKE CLEANING AGENT | 2001 |
|
RU2218388C2 |
| METHOD OF SHUTOFF OF WATER INFLOWS | 1999 |
|
RU2158352C1 |
| LIQUID ENZYME PREPARATION AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2712517C1 |
| PREPARATION OF TRANSPARENT AQUEOUS SOLUTION OF THERAPEUTICAL FORMS WITH BILE ACIDS | 2001 |
|
RU2277913C2 |
| ANTIBACTERIAL AGENT | 2010 |
|
RU2480239C2 |
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| GEL COMPOSITION FOR SKIN TREATMENT | 2020 |
|
RU2753638C2 |
| AGENT FOR INTRAVAGINAL DELIVERY OF ACTIVE COMPONENT, METHOD OF PRODUCTION AND USE OF THE MEDICINAL PRODUCT | 2022 |
|
RU2806114C2 |
| SUSPENSION CONTAINING HYDROXONIUM-STABILISED NANOPARTICLES OF COLLOIDAL SOLUTION OF SILICIC ACID, COMPOSITION PREPARED FROM SAID DILUTED SUSPENSION, POWDER PREPARED FROM SAID DEHYDRATED SUSPENSION, COMPOSITIONS PREPARED FROM SAID POWDER, PREPARATION AND USE | 2009 |
|
RU2488557C2 |
| THERMOSTABLE COMPOSITION, HAVING ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND USE THEREOF | 2017 |
|
RU2718554C1 |
